Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains

Brain Research

Volumn 971, Issue 2, 2003, Pages 197-209

  Nagele, Robert G ^a   D'Andrea, Michael R ^b   Lee, H ^c   Venkataraman, Venkateswar ^d   Wang, Hoau Yan ^e  

^a UMDNJ School of Osteopathic Medicine   (United States)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^e CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer's disease; Amyloid plaque; Astrocyte; Astrogliosis; Amyloid

Indexed keywords

ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR; AMYLOID BETA PROTEIN; CHOLINE ACETYLTRANSFERASE; CHOLINERGIC RECEPTOR; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BIOACCUMULATION; BRAIN CORTEX; BRAIN REGION; CELL DEGENERATION; CELL SPECIFICITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYSIS; MOLECULAR BIOLOGY; NERVE CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; SYNAPSE;

EID: 0037427384     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02361-8     Document Type: Article

References (65)

1. Akiyama H., Schwab C., Kondo H., Mori H., Kametani F., Ikeda K., McGeer P.L. Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of beta-amyloid protein. Neurosci. Lett. 206:1996;169-172.
2. Akiyama H., Mori H., Saido T., Kondo H., Ikeda K., McGeer P.L. Occurrence of the diffuse amyloid beta-protein (Abeta) deposits with numerous Abeta-containing glial cells in the cerebral cortex of patients with Alzheimer's disease. Glia. 25:1999;324-331.
3. Aldskogius H., Liu L., Svensson M. Glial responses to synaptic damage and plasticity. J. Neurosci. Res. 58:1999;33-41.
4. Araque A., Carmignoto G., Haydon P.G. Dynamic signaling between astrocytes and neurons. Annu. Rev. Physiol. 63:2001;795-813.
5. Banerjee C., Nyengaard J.R., Wevers A., deVos R.A., Jansen Steur E.N., Lindstrom J., Pilz K., Nowacki S., Bloch W., Schroder H. Cellular expression of alpha7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer's and Parkinson's disease - a stereological approach. Neurobiol. Dis. 7:2000;666-672.
6. Bechmann I., Nitsch R. Astrocytes and microglial cells incorporate degenerating fibers following entorhinal lesion: a light, confocal, and electron microscopical study using phagocytosis-dependent labeling technique. Glia. 20:1997;145-154.
7. Burghaus L., Schutz U., Krempel U., de Vos R.A., Jansen Steur E.N., Wevers A., Lindstrom J. Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients. Brain Res. Mol. Brain Res. 76:2000;385-388.
8. Busciglio J., Pelsman A., Wong C., Pigino G., Yuan M., Mori H., Yankner B.A. Altered metabolism of the amyloid B precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron. 33:2002;677-688.
9. Cheng H.W., Jiang T., Brown S.A., Pasinetti G.M., Finch C.E., McNeill T.H. Response of striatal astrocytes to neuronal differentiation: an immunocytochemical and ultrastructural study. Neuroscience. 62:1994;425-439.
10. Citron M., Diehl T.S., Gordon G., Biere A.L., Seubert P., Selkoe D.J. Evidence that the 42- and 40-amino acid forms of amyloid β protein are generated from the β-amyloid precursor protein by different protease activities. Proc. Natl. Acad. Sci. USA. 93:1996;13170-13175.
11. D'Andrea M.R., Nagele R.G., Wang H.-Y., Lee D.H.S. Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology. 38:2001;120-134.
12. D'Andrea M.R., Reiser P.A., Gumula N.A., Hertzog B.M., Andrade-Gordon P. Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease. Biotech. Histochem. 76:2001;97-106.
13. Davies C.M., Mann D.M., Sumpter P.Q., Yates P.O. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J. Neurol. Sci. 78:1987;151-164.
14. Davis K.L., Mohs R.C., Marin D., Purohit D.P., Perl D.P., Lamtz M., Austin G., Haroutunian V. Cholinergic markers in elderly patients with early signs of Alzheimer disease. J. Am. Med. Assoc. 281:1999;1401-1406.
15. DeKosky S.T., Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27:1990;457-464.
16. Eng L.F., Ghirnikar R.S. GFAP and astrogliosis. Brain Pathol. 4:1994;229-237.
17. Eng L.F., Yu A.C.H., Lee Y.L. Astrocytic response to injury. Prog. Brain. Res. 94:1992;353-365.
18. Fitch M.T., Silver J. Glial cell extracellular matrix: boundaries for axon growth in development and regeneration. Cell Tissue Res. 290:1997;379-384.
19. Funato H., Yoshimura M., Yamazaki T., Saido T.C., Ito Y., Yokofujita J., Okeda R., Ihara Y. Astrocytes containing amyloid beta-protein (Abeta)-positive granules are associated with Aβ40-positive diffuse plaques in the aged human brain. Am. J. Pathol. 152:1998;983-992.
20. Games D., Adams R., Alessandrini R., et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature. 373:1995;523-527.
21. Goldgaber D., Lerman M.I., McBride O.W., Saffiotti U., Gajdusek D.C. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science. 235:1987;877-880.
22. Gouras G.K., Tsaiu J., Naslund J., Vincent B., Edgar M., Checler F., Greenfield J.P., Haroutunian V., Buxbaum J.D., Xu H., Greengard P., Relkin N.R. Intraneuronal Aβ42 accumulation in human brain. Am. J. Pathol. 156:2000;15-20.
23. Griffin W.S.T., Sheng J.G., Royston M.C., Gentleman S.M., McKenzie J.E., Graham D.I., Roberts G.W., Mrak R.E. Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol. 8:1998;65-72.
24. Guan Z.Z., Zhang X., Ravid R., Nordberg A. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J. Neurochem. 74:2000;237-243.
25. Gyure K.A., Durham R., Stewart W.F., Smialek J.E., Troncoso J.C. Intraneuronal aβ-amyloid precedes development of amyloid plaques in Down syndrome. Arch. Pathol. Lab. Med. 125:2001;489-492.
26. Itagaki S., McGeer P.L., Akiyama H., Zhu S., Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 24:1989;173-182.
27. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik G.M., Beyreuther K., Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature. 325:1987;733-736.
28. Kurt M.A., Davies D.C., Kidd M.M. beta-Amyloid immunoreactivity in astrocytes in Alzheimer's disease brain biopsies: an electron microscope study. Exp. Neurol. 158:1999;221-228.
29. LaFerla F.M., Tinkle B.T., Bieberich C.J., Haudenschild C.C., Jay G. The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat. Genet. 9:1995;21-30.
30. Lee D.H.S., D'Andrea M.R., Plata-Salaman C.R., Wang H.-Y. Decreased α7 nicotinic acetylcholine receptor levels in sporadic Alzheimer's disease hippocampus. Alz. Rep. 3:2000;217-220.
31. Masters C., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA. 82:1985;4245-4249.
32. Moechars D., Dewachter I., Lorent K., Reverse D., Baekelandt V., Naidu A., Tesseur I., Spittaels K., Haute C.V., Checler F., Godaux E., Cordell B., Van Leuven F. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274:1999;6483-6492.
33. Mrak R.E., Griffin W.S. The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease. Neurobiol. Aging. 22:2002;915-922.
34. Nagele R.G., D'Andrea M.R., Anderson W.J., Wang H.-Y. Intracellular accumulation of B-amyloid in neurons is facilitated by the a7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience. 110:2002;199-211.
35. Neurobiol. Aging. 18:(suppl.):1997;s1-s2.
36. Nordberg A. Human nicotinic receptors - their role in aging and dementia. Neurochem. Int. 25:1994;93-97.
37. Otsuka N., Tomonaga M., Ikeda K. Rapid appearance of B-amyloid precursor immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury. Brain Res. 568:1991;335-338.
38. Rumble B., Retallack R., Hilbich C. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N. Engl. J. Med. 320:1989;1446-1452.
39. Sabbagh M.N., Reid R.T., Corey-Bloom J., Rao T.S., Hansen L.A., Alford M., Maslaih E., Adem A., Lloyd G.K., Thal L.J. Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease. J. Neural Transm. 105:1998;709-717.
40. Scheff S.W., Price D.A. Synaptic density in the inner molecular layer of the hippocampal dentate gyrus in Alzheimer disease. J. Neuropathol. Exp. Neurol. 57:1998;1146-1153.
41. Scheff S.W., Price D.A., Sparks D.L. Quantitative assessment of possible age-related change in synaptic numbers in the human frontal cortex. Neurobiol. Aging. 22:2001;355-365.
42. Scheuner D., Eckman C., Jensen M., et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2:1996;864-870.
43. Schroder H., Wevers A. Nicotinic acetylcholine receptors in Alzheimer's disease. Alz. Dis. Rev. 3:1998;20-27.
44. Schubert P., Ogata T., Marchini C., Ferroni S. Glia-related pathomechanisms in Alzheimer's disease: a therapeutic target? Mech. Ageing Dev. 123:2001;47-57.
45. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron. 6:1991;487-498.
46. Selkoe D.J. Normal and abnormal biology of the beta-amyloid precursor protein. Annu. Rev. Neurosci. 17:1994;489-517.
47. Selkoe D.J. The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8:1998;447-453.
48. Shaffer L.M., Dority M.D., Gupta-Bansal R., Frederickson R.C.A., Younkin S.G., Brunden K.R. Amyloid B protein (AB) removal by neuroglial cells in culture. Neurobiol. Aging. 16:1995;737-745.
49. Small D.H. The role of the amyloid protein precursor (APP) in Alzheimer's disease: does the normal function of APP explain the topography of neurodegeneration? Neurochem. Res. 23:1998;795-806.
50. Tanzi R.E., Vaula G., Romano D.M. Assessment of amyloid beta-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases. Am. J. Hum. Genet. 51:1992;273-282.
51. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30:1991;572-580.
52. Thal D.R., Hartig W., Schober R. Diffuse plaques in the molecular layer show intracellular AB8-17-immunoreactive deposits in subpial astrocytes. Clin. Neuropathol. 18:1999;226-231.
53. Thal D.R., Schultz C., Dehghani F., Yamaguchi H., Braak H., Braak E. Amyloid beta-protein (Abeta)-containing astrocytes are located preferentially near N-terminal-truncated Abeta deposits in the human entorhinal cortex. Acta Neuropathol. 100:2000;608-617.
54. Trojanowski J.Q., Lee V.M. Paired helical filament tau in Alzheimer's disease. The kinase connection. Am. J. Pathol. 14:1994;449-453.
55. Ullian E.M., Sapperstein S.K., Christopherson K.S., Barres B.A. Control of synapse number by glia. Science. 291:2001;657-661.
56. Vernadakis A. Glia-neuron intercommunications and synaptic plasticity. Prog. Neurobiol. 49:1996;185-214.
57. 1-42 binds to α7 nicotinic acetylcholine receptor with high affinity: implications for Alzheimer's disease pathology. J. Biol. Chem. 275:2000;5626-5632.
58. Wang H.-Y., D'Andrea M.R., Nagele R.G. Cerebellar diffuse amyloid plaques are derived from dendritic Aβ42 accumulations in Purkinje cells. Neurobiol. Aging. 23:2002;213-223.
59. Whitehouse P.J., Kalaria R.N. Nicotinic receptors and neurodegenerative dementing diseases: basic research and clinical implications. Alzheimer Dis. Assoc. Disord. 9:1995;3-5.
60. Wirths O., Multhaup G., Czech C., Blanchard V., Moussaoui S., Tremp G., Pradier L., Beyreuther K., Bayer T.A. Intraneuronal AB accumulation precedes plaque formation in β-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci. Lett. 306:2001;116-120.
61. Wisniewski K.E., Wisniewski H.M., Wen G.Y. Occurrance of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17:1985;278-282.
62. Xu K., Malouf A.T., Messing A., Silver J. Glial fibrillary acidic protein is necessary for mature astrocytes to react to B-amyloid. Glia. 25:1999;390-403.
63. Yamaguchi H., Sugihara S., Ogawa A., Saido T.C., Ihara Y. Diffuse plaques associated with astroglial amyloid beta protein, possibly showing a disappearing stage of senile plaques. Acta Neuropathol. 95:1998;217-222.
64. Younkin S.G. Evidence that Abeta 42 is the real culprit in Alzheimer's disease. Ann. Neurol. 37:1995;287-288.
65. Zhao J., Paganini L., Mucke L., Gordon M., Refolo L., Carman M., Sinha S., Oltersdorf T., Lieberburg I., McConlogue L. Beta-secretase processing of the beta-amyloid precursor protein in transgenic mice is efficient in neurons but inefficient in astrocytes. J. Biol. Chem. 271:1996;31407-31411.